期刊
CANCER EPIDEMIOLOGY
卷 33, 期 3-4, 页码 281-287出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.canep.2009.08.006
关键词
Glutaredoxin; PKC-interacting cousin of thioredoxin (PICOT); Overexpression; Colon cancer; Lung cancer
资金
- Regional Research and Development Cluster Project [130009735]
- Ministry of Knowledge Economy (MKE) of Korea
Glutaredoxin (Glrx) uses the reducing power of glutathione to maintain and regulate the cellular redox state. Substantial evidence indicates that the alteration of cellular redox status is a critical factor involved in cell growth and death and results in tumorigenesis. We investigated levels of expression of all Glrx genes in a variety of cancers using a real-time polymerase chain reaction (RT-PCR). Among members of the Glrx, family, Glrx3 (PICOT: PKC-interacting cousin of thioredoxin) was preferentially induced in lung (55.3 +/- 30.1-fold induction) and colon (50.2 +/- 28.8-fold induction) cancer compared to their normal tissues (lung colon > breast > ovary > bladder > prostate > thyroid > lymphoma > liver > kidney cancers). By contrast, the magnitude of induction folds in other cancer tissues was ranged from 0.83 to 4.0. Moreover, the induction folds of Glrx3 mRNA in colon and lung cancer tissues were significantly higher when compared to those of all thioredoxin (Trx) and peroxiredoxin (Prx) members. Western blot analysis of different and paired cancer tissues revealed the consistent and preferential expression of Glrx3 in lung and colon cancers. Taken together, these results suggest that Glrx3 could take a pivotal role in colon and lung cancer cells during the tumorigenesis. (C) 2009 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据